Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 11

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 11
---
 from 100,000,000 shares to
800,000,000 shares (the “Charter Amendment Proposal”), at a special meeting of stockholders expected to be held on April 29, 2025.

On March 7, 2025, the Company
also entered into a placement agency agreement with R.F. Lafferty & Co., Inc. (“R.F. Lafferty”) as the sole placement
agent in connection with the Private Placement (the “Placement Agent”). As compensation to the Placement Agent, the Company
will pay a commission equal to 7.0% of the aggregate gross proceeds from the Private Placement.

The Private Placement closed
on March 10, 2025. The Securities issued in the Private Placement were issued and offered pursuant to the exemptions from registration
provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.

Implications of Being an Emerging Growth Company and Smaller Reporting Company

We are an “emerging
growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). We may take advantage
of certain exemptions from various public company reporting requirements, including not being required to have our internal control over
financial reporting audited by our independent registered public accounting firm under Section 404 of the Sarbanes-Oxley Act of 2002 (the
“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments.
We may take advantage of these exemptions until the last day of our fiscal year following the fifth anniversary of the date of the first
sale of our common equity securities pursuant to an effective registration statement under the Securities Act or until we are no longer
an “emerging growth company,” whichever is earlier. We will cease to be an emerging growth company prior to the end of such
period if certain earlier events occur, including if we become a “large accelerated filer” as defined in Rule 12b-2 under
the Exchange Act, our annual gross revenues exceed $1.235 billion or we issue more than $1.0 billion of non-convertible debt in any three-year
period.

Under the JOBS Act, emerging
growth companies can also delay adopting new or revised accounting standards until such time as those standards